Differences in in vivo and in vitro sequence-specific sites of cisplatin-DNA adduct formation and detection of a dose-response relationship
- 5 July 1994
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 48 (1) , 145-153
- https://doi.org/10.1016/0006-2952(94)90234-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogs, including two acridine-tethered complexes with DNA inside human cellsBiochemistry, 1992
- Transcription by eukaryotic and prokaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II)Biochemistry, 1991
- Spectrum ofcis-diamminedichloroplatinum(II)-induced mutations in a shuttle vector propagated in human cellsMolecular Carcinogenesis, 1991
- A human alphoid DNA clone from the EcoRI dimeric family: Genomic and internal organization and chromosomal assignmentGenomics, 1989
- Binding of cisplatin to specific sequences of human DNA in vitroMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985
- A protein binds to a satellite DNA repeat at three specific sites that would be brought into mutual proximity by DNA folding in the nucleosomeCell, 1984
- High-performance liquid chromatographic determination of platinum (II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrometric methodClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Nucleosome arrangement in green monkey α-satellite chromatinJournal of Molecular Biology, 1983
- Chemical CarcinogenesisNew England Journal of Medicine, 1981